首页 > 市场调查报告书 > 医疗设备

生技设备

市场调查报告书

商品编码

1596822

细胞分析市场规模、份额和成长分析（按产品/服务、按方法、按流程、按最终用户、按地区）：产业预测 (2024-2031)

Cell Analysis Market Size, Share, Growth Analysis, By Product & Service, By Technique, By Process, By End User By Region -Industry Forecast 2024-2031.

出版日期: 2024年11月19日 | 出版商:

SkyQuest | 英文 209 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2022年全球细胞分析市场规模为195亿美元，从2023年的216.1亿美元扩大到2031年的490.8亿美元，在预测期内（2024-2031年）预计复合年增长率为10.80%。。

由于慢性病盛行率上升、细胞分析技术的持续进步以及药物发现活动的活性化，预计细胞分析市场将在 2024 年显着成长。随着心血管疾病、癌症、自体免疫疾病和类风湿性关节炎等慢性疾病变得更加普遍，对有效细胞分析工具的需求预计将激增。这些工具对于确定慢性病患者的潜在治疗方案至关重要。对癌症诊断的日益关注凸显了这一趋势，Serum Detect 等组织在创新 T 细胞测试方面处于领先地位，例如 T 细胞测试，该测试于 2024 年 3 月获得美国癌症研究协会 (AACR) 提名。方法受到了讚扬。此类倡议反映了医疗产业对加强细胞诊断能力的承诺，这对于市场扩张至关重要。此外，被动生物分离系统和细胞分析中其他先进技术的发展显着提高了结果的准确性和效率，进一步增加了市场潜力。随着情势的发展，最尖端科技的整合和对慢性疾病的更深入了解将继续推动细胞分析领域的成长和创新。

北美（按产品/服务、方法、流程、最终用户）
- 美国
- 加拿大
欧洲（按产品/服务、方法、流程、最终用户）
- 英国
- 德国
- 西班牙
- 法国
- 义大利
- 其他欧洲国家
亚太地区（依产品/服务、方法、流程、最终用户）
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲（按产品/服务、方法、流程、最终用户）
- 巴西
- 其他拉丁美洲
中东/非洲（按产品/服务、方法、流程、最终用户）
- 波湾合作理事会(GCC) 国家
- 南非
- 其他中东/非洲

竞争资讯

前5名企业对比
主要企业市场定位（2023年）
主要市场参与者所采取的策略
近期市场趋势
公司市场占有率分析（2023）
主要企业简介
- 公司简介
- 产品系列分析
- 按细分市场分類的份额分析
- 年比收益成长（YoY）比较（2021-2023）

主要企业简介

Thermo Fisher Scientific Inc.
Danaher
Becton, Dickinson and Company (BD)
General Electric
Merck KGAA
Agilent Technologies, Inc.
Bio-rad Laboratories, Inc.
Standard Biotools
Miltenyi Biotec
Olympus Corporation
Biostatus Limited
Nanocellect Biomedical
Creative Bioarray
Meiji Techno
Promega Corporation
Perkinelmer US LLC
Tecan Trading AG
Carl Zeiss AG
Sysmex
Qiagen

结论和建议

简介目录

Product Code: SQMIG35H2316

Global Cell Analysis Market size was valued at USD 19.5 billion in 2022 and is poised to grow from USD 21.61 billion in 2023 to USD 49.08 billion by 2031, growing at a CAGR of 10.80% during the forecast period (2024-2031).

The cell analysis market is poised for significant growth in 2024, driven by the rising incidence of chronic diseases, continuous advancements in cellular analysis technologies, and an uptick in drug discovery activities. As chronic conditions such as cardiovascular diseases, cancers, autoimmune disorders, and rheumatoid arthritis become more prevalent, the demand for effective cellular analysis tools is expected to surge. These tools are critical in identifying potential therapeutic options for patients battling chronic illnesses. The increasing focus on cancer diagnostics highlights this trend, with organizations like Serum Detect gaining recognition for innovative approaches, such as their T-cellular testing nominated by the American Association for Cancer Research (AACR) in March 2024. Such initiatives reflect the healthcare industry's commitment to enhancing cellular diagnostic capabilities, which is essential for market expansion. Additionally, the development of passive bioseparation systems and other advanced technologies in cell analysis has significantly improved both the accuracy and efficiency of results, further bolstering market potential. As the landscape evolves, the integration of cutting-edge technologies and a deeper understanding of chronic diseases will continue to drive growth and innovation within the cell analysis sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cell Analysis market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cell Analysis Market Segmental Analysis

Global Cell Analysis Market is segmented into Product & Service, Technique, Process, end user, and region. By Product & Service, the market is classified into Reagents & Consumables, Instruments, Accessories, Software, and Services. Depending on the Technique, it is categorized into Flow Cytometry, PCR, Cell Microarrays, Microscopy, Spectrophotometry, High-Content Screening, and Other Techniques. By Process, the market is classified into Cell Identification, Cell Viability, Cell Signaling Pathway/Signal Transduction, Cell Proliferation, Cell Counting and Quality Control, Cell Interaction, Cell Structure Study, Target Identification and Validation, and Single-Cell Analysis. According to End User, the market is divided into Pharmaceutical and Biotechnology Companies, Hospitals and Clinical Testing Laboratories, Academic and Research Institutes, and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Cell Analysis Market

The Global Cell Analysis market is being significantly propelled by the rising demand for personalized medicine. Advances in molecular biology and genomics are making it possible to tailor treatments to individual patients based on their unique genetic profiles. This shift towards customization in therapeutic approaches is revolutionizing healthcare, as it enhances the understanding of disease mechanisms at the cellular level. Consequently, biotech innovations facilitate improved diagnostics and enable targeted therapies, which contribute to the overall growth of the cell analysis market. This growing trend emphasizes the importance of developing effective and individualized treatment options, further driving market expansion.

Restraints in the Global Cell Analysis Market

One significant constraint facing the global cell analysis market is the elevated costs linked to advanced equipment and technology. Essential tools such as flow cytometers, cell counters, and imaging systems necessitate substantial initial investments, which can be a barrier for smaller laboratories and research institutions. Additionally, the ongoing expenses related to the maintenance and upgrading of these sophisticated devices further impede market expansion. As a result, the financial burden associated with acquiring and sustaining high-quality cell analysis equipment may limit accessibility and capabilities, posing challenges to the overall growth and development of the sector.

Market Trends of the Global Cell Analysis Market

The Global Cell Analysis market is experiencing a significant shift driven by rapid technological advancements in single-cell analysis. As researchers increasingly adopt methods like single-cell RNA sequencing and high-throughput single-cell assays, this trend is unlocking unprecedented insights into cellular processes, differentiation, and disease mechanisms that were previously unattainable with bulk analysis techniques. This innovation is particularly impactful in fields such as cancer research, immunology, and regenerative medicine, fostering enhanced understanding and treatment strategies. As these technologies become more accessible and integrated into standard research and clinical applications, the demand for sophisticated cell analysis tools is projected to continue growing, shaping the market's trajectory through 2024 and beyond.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Driver & Opportunities
- Restraints & Challenges
Porters Analysis & Impact
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Technological Advancement
Regulatory Landscape
Case Study Analysis
Customer & Buying Criteria Analysis
PESTEL Analysis
Startup Analysis
Market Attractiveness Index
Pricing Analysis

Global Cell Analysis Market Size by Product & Service & CAGR (2024-2031)

Market Overview
Reagents & Consumables
Instruments
Accessories
Software
Services

Global Cell Analysis Market Size by Technique & CAGR (2024-2031)

Market Overview
Flow Cytometry
PCR
Cell Microarrays
Microscopy
Spectrophotometry
High-Content Screening
Other Techniques

Global Cell Analysis Market Size by Process & CAGR (2024-2031)

Market Overview
Cell Identification
Cell Viability
Cell Signaling Pathway/Signal Transduction
Cell Proliferation
Cell Counting and Quality Control
Cell Interaction
Cell Structure Study
Target Identification and Validation
Single-Cell Analysis

Global Cell Analysis Market Size by End User & CAGR (2024-2031)

Market Overview
Pharmaceutical And Biotechnology Companies
Hospitals And Clinical Testing Laboratories
Academic And Research Institutes
Other End Users

Global Cell Analysis Market Size & CAGR (2024-2031)

North America, (Product & Service, Technique, Process, End User)
- US
- Canada
Europe, (Product & Service, Technique, Process, End User)
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific, (Product & Service, Technique, Process, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
Latin America, (Product & Service, Technique, Process, End User)
- Brazil
- Rest of Latin America
Middle East & Africa, (Product & Service, Technique, Process, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2023
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

Thermo Fisher Scientific Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company (BD)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
General Electric
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGAA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-rad Laboratories, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Standard Biotools
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Miltenyi Biotec
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Olympus Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biostatus Limited
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nanocellect Biomedical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Creative Bioarray
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Meiji Techno
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Promega Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Perkinelmer U.S. LLC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Tecan Trading AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Carl Zeiss AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sysmex
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Qiagen
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments